Prof. Ru Chih Huang, Ph.D.
Botanical drugs are complex
Multiple chemical components
Not well-defined active component(s)
Botanical products intended to be marketed as drugs in the United States are expected to meet the same standards as non-botanical drugs for quality, safety, and efficacy.
Level of clinical efficacy and safety requirements is the same for botanical and non-botanical drugs